These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8089682)

  • 1. Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome.
    Exley AR; Smith N; Winer JB
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1118-20. PubMed ID: 8089682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK; McLean B; Thompson EJ
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome.
    Sharief MK; Ingram DA; Swash M
    Ann Neurol; 1997 Jul; 42(1):68-73. PubMed ID: 9225687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function.
    Créange A; Bélec L; Clair B; Degos JD; Raphaël JC; Gherardi RK
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):162-5. PubMed ID: 9489524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating cytokines in patients with myocarditis and cardiomyopathy.
    Matsumori A; Yamada T; Suzuki H; Matoba Y; Sasayama S
    Br Heart J; 1994 Dec; 72(6):561-6. PubMed ID: 7857740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome.
    Li C; Zhao P; Sun X; Che Y; Jiang Y
    Mediators Inflamm; 2013; 2013():639712. PubMed ID: 24174711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium fusidate in Gillain-Barré syndrome: a case report.
    Nicoletti F; Nicoletti A; Giuffrida S; Di Marco R; Meroni P; Bendtzen K; Lunetta M
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):266-8. PubMed ID: 9703187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome.
    Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
    Acta Neurol Scand; 2004 Jan; 109(1):71-4. PubMed ID: 14653854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome.
    Créange A; Bélec L; Clair B; Raphaël JC; Gherardi RK
    J Neuroimmunol; 1996 Aug; 68(1-2):95-9. PubMed ID: 8784265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
    Hartung HP; Heininger K; Toyka KV
    Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated number of cells secreting transforming growth factor beta in Guillain-Barré syndrome.
    Dahle C; Kvarnstrom M; Ekerfelt C; Samuelsson M; Ernerudh J
    APMIS; 2003 Dec; 111(12):1095-104. PubMed ID: 14678018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated neopterin levels in Guillain-Barré syndrome. Further evidence of immune activation.
    Bansil S; Mithen FA; Singhal BS; Cook SD; Rohowsky-Kochan C
    Arch Neurol; 1992 Dec; 49(12):1277-80. PubMed ID: 1449407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome.
    Sharief MK; Ingram DA; Swash M; Thompson EJ
    Neurology; 1999 Jun; 52(9):1833-8. PubMed ID: 10371531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-inflammatory cytokines, lymphocyte subsets and intravenous immunoglobulin therapy in Guillain-Barré syndrome.
    Tekgül H; Kütükçüler N; Cağlayan S; Tütüncüoğlu S
    Turk J Pediatr; 1998; 40(3):357-63. PubMed ID: 9763899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from Guillain-Barré syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma.
    Elkarim RA; Dahle C; Mustafa M; Press R; Zou LP; Ekerfelt C; Ernerudh J; Link H; Bakhiet M
    Clin Immunol Immunopathol; 1998 Sep; 88(3):241-8. PubMed ID: 9743610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders.
    Weller M; Stevens A; Sommer N; Melms A; Dichgans J; Wiethölter H
    J Neurol Sci; 1991 Aug; 104(2):215-21. PubMed ID: 1940975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ben-Smith A; Gaston JS; Barber PC; Winer JB
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):362-8. PubMed ID: 8890774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of circulating inflammatory cytokines in patients during an acute attack of bronchial asthma.
    Subratty AH; Hooloman NK
    Indian J Chest Dis Allied Sci; 1998; 40(1):17-21. PubMed ID: 9727279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.